Better delivery of standard antithrombotic care

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 1038-1042

  Bussey, Henry ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

ANTICOAGULANT THERAPY; BLEEDING; CONFERENCE PAPER; HEALTH CARE DELIVERY; HEART VALVE PROSTHESIS; HUMAN; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS;

EID: 0035370248     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.115528     Document Type: Conference Paper

References (23)

1. Stein PD, Alpert JS, Bussey HI, et dl. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220-75.
2. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-30.
3. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-16.
4. Loeliger EA. Therapeutic target values in oral anticoagulation: justification of Dutch policy and a warning against the so-called moderate-intensity regimens. Ann Hematol 1992;64:60-5.
5. Turpie AGG, Laupacis A, Hirsh J. Warfarin and aspirin after heart valve replacement [letter]. N Engl J Med 1994;330:508-9.
6. Saour JN, Seek JO, Mamo LAR, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322:428-32.
7. Bussey HI, Force RW, Bianco TM, et al. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med 1992;152:278-82.
8. Cannegieter SC, Rosendaal Fr, Wintzen AR, et al. Optimal oral anticoagulation therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7.
9. Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-9.
10. Meschengieser SS, Fondevila CG, Frontroth J, et al. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113:910-6.
11. Pouleur H, Buyse M. Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves: a meta-analysis of the randomized trials. J Thorac Cardiovasc Surg 1995;110:463-72.
12. Garabedian-Ruffalo SM, Gray DR, Sax MJ, et al. Retrospective evaluation of a pharmacists-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-5.
13. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prostheses attending an anticoagulation clinic. Thromb Haemost 1993;69:316-20.
14. Pell JP, McIver B, Stuart P, et al. Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic. Br J Gen Prac 1993;43:152-4.
15. Wilt VM, Gums JG, Ahmed OI, et al. Outcome analysis of a pharmacist-managed anticoagulation service: pharmacotherapy 1995; 15:732-3.
16. Lee Y-P, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions. Am J Health-System Pharm 1996;53:1580-3.
17. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Int Med 1998;158:1641-7.
18. Witt DM, Tillman DF. Clinical pharmacy anticoagulation services in a group model health maintenance organization. Pharm Pract Man Q 1998;18:34-55.
19. Pubentz MF, Calcagno DE, Teeters JL. Improving warfarin anticoagulation therapy in a community health system. Pharm Pract Man Q 1998;18:1-16.
20. Foss MT, Schoch PH, Sintek CD. Efficient operation of a high-volume anticoagulation clinic. Am J Health-System Pharm 1999;56:443-9.
21. Rosendaal FR, Cannegieter SC, van der Meer FJM, et al. A method to determine the optimal intensity of oral anticoaglant therapy. Thromb Haemost 1993;69:236-9.
22. Fairweather RB, Ansell J, van den Besselaar MHP, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 1998;122:768-81.
23. Bussey HI, Chiquette E, Bianco TM, et al. A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy 1997;17:861-6.